On the other hand, the observation that a fraction of HG-BCL w/DH can be cured with standard therapies underlines the concept that the mechanisms underlying chemoresistance in MYC/BCL-2 positive DLBCL are still poorly defined. Here, BCL2 is linked to diffuse large B-cell lymphoma.